Latest Revenue Growth News

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

BSA Limited reported a mixed Q2 FY2026 with improved EBITDA margins and completed restructuring, yet faces ongoing risks from lost contracts and uncertain second-half profitability.

Swoop Holdings reports a robust 53% increase in customer receipts for the first half of FY26, driven by NBN and Mobile growth, while investing heavily in technology and launching a strategic refocus.

Unith Ltd reports a 17% rise in quarterly cash receipts alongside strategic funding and new technology launches, signalling momentum in its AI-driven digital human platform.

Careteq Limited reported a disciplined operating cash flow in Q2 FY26 with strong growth in its Embedded Health Solutions segment and ongoing resolution of an ATO tax incentive dispute.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

CONNEQT Health has reported a remarkable surge in Pulse device sales, exceeding 200% growth quarter-on-quarter, while advancing its transition to a recurring revenue model through enterprise contracts and consumer subscriptions.

AdNeo Limited reported a striking 89% increase in customer receipts in Q2 FY26, driven by recent acquisitions and strong contract wins, edging close to cash flow positivity. The company’s strategic cost reductions and expanding sales pipeline signal promising momentum for the remainder of the year.

RooLife Group Limited (ASX, RLG) reported a strong Q2 FY2026 with revenue climbing to $3.25 million, driven by rapid growth in its RLG Coffee range in China. The company’s lean, data-driven marketplace model is scaling efficiently despite expected seasonal slowdowns.

XPON Technologies Group delivered a robust Q1 FY26 with an 8.3% revenue increase and positive operating cash flow, underpinned by successful Alpha Digital integration and strong recurring revenue.

Noumi Limited reported a 13.4% revenue increase in Q2 FY26 driven by strong growth in its Dairy and Nutritionals and Plant-based Milks segments, despite a $4.5 million operating cash outflow impacted by legal expenses. The company’s Milklab brand continues to gain traction both domestically and internationally.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.